Analysts See $0.10 EPS for American Renal Associates Holdings, Inc. (ARA); Suncoke Energy Has 1.36 Sentiment

April 18, 2018 - By Louis Casey

Analysts expect American Renal Associates Holdings, Inc. (NYSE:ARA) to report $0.10 EPS on May, 8.They anticipate $0.04 EPS change or 66.67% from last quarter’s $0.06 EPS. ARA’s profit would be $3.21 million giving it 42.48 P/E if the $0.10 EPS is correct. After having $0.18 EPS previously, American Renal Associates Holdings, Inc.’s analysts see -44.44% EPS growth. The stock increased 2.53% or $0.42 during the last trading session, reaching $16.99. About 140,767 shares traded. American Renal Associates Holdings, Inc. (NYSE:ARA) has risen 13.61% since April 18, 2017 and is uptrending. It has outperformed by 2.06% the S&P500.

Suncoke Energy Inc (SXC) investors sentiment increased to 1.36 in 2017 Q4. It’s up 0.34, from 1.02 in 2017Q3. The ratio is positive, as 79 investment professionals increased or started new holdings, while 58 sold and reduced their stakes in Suncoke Energy Inc. The investment professionals in our database now hold: 55.70 million shares, down from 57.36 million shares in 2017Q3. Also, the number of investment professionals holding Suncoke Energy Inc in top ten holdings decreased from 2 to 1 for a decrease of 1. Sold All: 9 Reduced: 49 Increased: 49 New Position: 30.

The stock increased 2.58% or $0.28 during the last trading session, reaching $11.12. About 151,627 shares traded. SunCoke Energy, Inc. (SXC) has risen 19.21% since April 18, 2017 and is uptrending. It has outperformed by 7.66% the S&P500.

SunCoke Energy, Inc. operates as an independent producer of coke in the Americas. The company has market cap of $718.22 million. The firm operates through four divisions: Domestic Coke, Brazil Coke, Coal Logistics, and Coal Mining. It has a 5.91 P/E ratio. The firm offers metallurgical and thermal coal.

Analysts await SunCoke Energy, Inc. (NYSE:SXC) to report earnings on April, 26 before the open. They expect $0.03 earnings per share, up 50.00% or $0.01 from last year’s $0.02 per share. SXC’s profit will be $1.94 million for 92.67 P/E if the $0.03 EPS becomes a reality. After $0.14 actual earnings per share reported by SunCoke Energy, Inc. for the previous quarter, Wall Street now forecasts -78.57% negative EPS growth.

Mangrove Partners holds 5.04% of its portfolio in SunCoke Energy, Inc. for 3.12 million shares. Gendell Jeffrey L owns 2.07 million shares or 1.72% of their US portfolio. Moreover, Menta Capital Llc has 0.42% invested in the company for 181,729 shares. The Us-based Ancora Advisors Llc has invested 0.25% in the stock. Nuveen Asset Management Llc, a Illinois-based fund reported 2.73 million shares.

Among 4 analysts covering American Renal Associates (NYSE:ARA), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. American Renal Associates had 6 analyst reports since May 16, 2016 according to SRatingsIntel. The rating was initiated by Suntrust Robinson with “Buy” on Monday, May 16. The rating was maintained by Barclays Capital on Friday, August 19 with “Overweight”. The rating was initiated by Goldman Sachs with “Neutral” on Monday, May 16. On Monday, May 16 the stock rating was initiated by Wells Fargo with “Outperform”. As per Thursday, May 11, the company rating was upgraded by Wells Fargo. The company was initiated on Monday, May 16 by Barclays Capital.

American Renal Associates Holdings, Inc. operates as a dialysis services well-known provider in the United States, focuses exclusively on joint venture partnerships with physicians. The company has market cap of $544.94 million. The company, through its subsidiaries, offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. It currently has negative earnings. As of December 31, 2016, it owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating approximately 14,000 patients in 25 states and the District of Columbia.

SunCoke Energy, Inc. (NYSE:SXC) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>